Jeryl L. Hilleman - 09 Jun 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Director
Signature: By: /s/ Steven Robbins, Attorney in Fact for Jeryl L. Hilleman
Issuer symbol: NVCR
Transactions as of: 09 Jun 2021
Net transactions value: -$266,713
Form type: 4
Filing time: 11 Jun 2021, 16:21:25 UTC
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Restricted Stock Units	Award	$0	+814	+24%	$0.000000	4,214	09 Jun 2021	Direct	F1
transaction	NVCR	Ordinary Shares	Disposed to Issuer	$266,713	-1,270	-30%	$210.01^*	2,944	09 Jun 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Options to Buy Ordinary Shares	Award	$0	+1,499		$0.000000	1,499	09 Jun 2021	Ordinary Shares	1,499	$211.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
F2	Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman.
F3	Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.